SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$598,000
-72.5%
18,100
-61.7%
0.01%
-76.2%
Q1 2022$2,175,000
+12.4%
47,293
+62.0%
0.04%
-17.6%
Q4 2021$1,935,000
-19.7%
29,193
-24.4%
0.05%
+15.9%
Q3 2021$2,409,000
+72.2%
38,595
+128.4%
0.04%
+69.2%
Q2 2021$1,399,00016,8970.03%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,328$51,213,00030.37%
JOHNSON & JOHNSON 3,260,869$203,576,00017.86%
ACT CAPITAL MANAGEMENT, LLC 194,000$12,111,0006.28%
Aquilo Capital Management, LLC 527,926$32,958,0005.99%
Evolutionary Tree Capital Management, LLC 105,491$6,586,0002.92%
ACUTA CAPITAL PARTNERS, LLC 121,500$7,585,0002.68%
L1 Capital Pty Ltd 297,915$18,599,0002.31%
Avidity Partners Management LP 673,700$42,059,0000.93%
Hood River Capital Management LLC 338,734$21,147,0000.65%
Tygh Capital Management, Inc. 64,127$4,003,0000.54%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders